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Abstract
In order to identify early abnormalities in non-insulin-dependent
diabetes mellitus (NIDDM) we determined insulin (using an assay that
does not cross-react with proinsulin) and proinsulin concentrations.
The proinsulin/insulin ratio was used as an indicator of abnormal ß-
cell function. The ratio of the first 30-min increase in insulin to
glucose concentrations following the oral glucose tolerance test (OGTT;
I30-0/G30-0) was taken as an indicator of insulin secretion. Insulin
resistance (R) was evaluated by the homeostasis model assessment
(HOMA) method. True insulin and proinsulin were measured during
a 75-g OGTT in 35 individuals: 20 with normal glucose tolerance
(NGT) and without diabetes among their first-degree relatives (FDR)
served as controls, and 15 with NGT who were FDR of patients with
NIDDM. The FDR group presented higher insulin (414 pmol/l vs 195
pmol/l; P = 0.04) and proinsulin levels (19.6 pmol/l vs 12.3 pmol/l; P
= 0.03) post-glucose load than the control group. When these groups
were stratified according to BMI, the obese FDR (N = 8) showed
higher fasting and post-glucose insulin levels than the obese NGT (N
= 9) (fasting: 64.8 pmol/l vs 7.8 pmol/l; P = 0.04, and 60 min post-
glucose: 480.6 pmol/l vs 192 pmol/l; P = 0.01). Also, values for
HOMA (R) were higher in the obese FDR compared to obese NGT
(2.53 vs 0.30; P = 0.075). These results show that FDR of NIDDM
patients have  true hyperinsulinemia (which is not a consequence of
cross-reactivity with proinsulin) and hyperproinsulinemia and no
dysfunction of a qualitative nature in ß-cells.
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Introduction
Non-insulin-dependent diabetes mellitus
(NIDDM) is a heterogeneous disorder char-
acterized by insulin resistance, decreased
insulin secretion and increased hepatic glu-
cose production. The role of these abnor-
malities as the earliest or primary causative
factors of NIDDM is controversial. How-
ever, studies on individuals at high risk to
develop the disease, such as offspring of
patients with NIDDM and certain population
groups, have provided important informa-
tion. A decrease in insulin sensitivity has
been found to precede and to predict the
development of NIDDM, possibly occurring
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15 to 25 years before the clinical onset of the
disease in genetically predisposed individu-
als (1-3).
In the present study we determined con-
centrations of proinsulin and insulin (using
an assay that does not cross-react with proin-
sulin) in response to an oral glucose load in
individuals with normal glucose tolerance
(NGT) who were relatives of NIDDM pa-
tients and in control individuals with no
family history of diabetes mellitus.
Subjects and Methods
Twenty-seven non-diabetic first-degree
relatives (FDR) of NIDDM and 21 non-
diabetic subjects with no family history of
diabetes were studied. All subjects under-
went a standard 75-g oral glucose tolerance
test (OGTT) and were classified as having
NGT, impaired glucose tolerance (IGT) or
diabetes mellitus (DM) on the basis of the
World Health Organization criteria (4). Only
the subjects with NGT were included in the
study, while 12 relatives (4 with NIDDM
and 8 with IGT) and 1 control with NIDDM
were excluded. Therefore, the study popula-
tion comprised 35 individuals: 20 subjects
with normal glucose tolerance and without
diabetes among their FDR (NGT group, 8
men and 12 women) served as normal con-
trols, and 15 with normal glucose tolerance
and FDR of patients with NIDDM (FDR
group, 5 men and 10 women). There were no
differences in age, sex distribution and body
mass index (BMI) between groups. NGT
and FDR groups were further divided into
obese (OB) with a BMI ³25 kg/m2 for women
and ³27 kg/m2 for men, and nonobese (L).
The clinical characteristics of the study popu-
lation are given in Table 1.
After a 12-h fast, blood for the determi-
nation of glycemia, insulinemia and proinsu-
linemia was withdrawn from each subject at
0, 30, 60, 90, 120 and 180 min after the
ingestion of 75 g glucose.
Plasma glucose was measured by the glu-
cose oxidase method (5). Proinsulin was
determined by an immunofluorimetric assay
using monoclonal antibodies as previously
described (6). Plasma insulin was also meas-
ured by a previously reported immunofluori-
metric method (7). In this assay, two mono-
clonal antibodies against insulin were pro-
duced: one was used for capture and the
other, labelled with europium, was used as
tracer antibody. The assay showed no cross-
reactivity with intact human proinsulin, des
31-32 proinsulin, split 32-33 (both produced
during proinsulin processing) and C-pep-
tide. The area under the glucose, insulin and
proinsulin curves was calculated as the sum
of half the fasting value plus the sum of the
values obtained at 30, 60, 90 and 120 min
and half the values obtained at 180 min (8).
The proinsulin/insulin molar ratio (PI/I)
was determined under fasting conditions.
Insulin secretion was measured as the ratio
of the increase in insulin to the increase of
glucose concentration at 30 min of the oral
glucose tolerance test (I30-0/G30-0) (9). Insu-
lin resistance (R) was evaluated using the
homeostasis model assessment, HOMA
(10).
Statistical analysis
The Mann-Whitney and Fisher exact tests
were used to compare two independent
groups not normally distributed. A P value
<0.05 was considered statistically signifi-
cant in all tests.
Table 1 - Clinical characteristics of study subjects.
Data are reported as medians. NGT, Normal glucose tolerance;
FDR, first-degree relatives; L, nonobese; OB, obese.
Group Sub-group N (M/F) Age (years) BMI (kg/m2)
NGT 20 (8/12) 31.5 25.2
NGT-L 11 (6/5) 30.0 23.4
NGT-OB 9 (2/7) 44.0 31.3
FDR 15 (7/8) 47.0 27.0
FDR-L 7 (4/3) 47.0 24.4
FDR-OB 8 (3/5) 43.5 31.0
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Results
First-degree relatives of NIDDM patients
had a higher prevalence of IGT or NIDDM
diagnosed by the OGTT compared to the
control group (12/27 vs 1/21; P = 0.02).
Mean fasting plasma glucose was not
significantly different between the FDR group
and their controls (NGT group). However,
after the oral glucose load, plasma glucose
levels showed a larger increase in the FDR
than in the controls at 60 min (Figure 1).
Also, the insulin levels at 60 min were
higher in the FDR group than in the NGT
group (Figure 2A). When these groups were
subdivided on the basis of BMI, no signifi-
cant differences in insulin levels were de-
tected between the nonobese subgroups (Fig-
ure 2B). In contrast, in the obese subgroups,
the relatives (FDR-OB) showed higher fast-
ing and 60-min post-glucose insulin levels
(P<0.05) compared with control (NGT-OB)
(Figure 2C). Figure 3A shows the plasma
proinsulin response during the OGTT of the
relatives and the controls. The FDR group
had higher values at 90 min compared to the
NGT group. No differences were found be-
tween NGT-L and FDR-L (Figure 3B) or
between NGT-OB and FDR-OB (Figure 3C).
However, when obese and nonobese sub-
jects from the NGT group were compared,
the NGT-OB had higher proinsulin at all
times along the curve than the NGT-L
(P<0.05). In contrast, no difference was found
between obese and nonobese subjects in the
FDR group.
No differences were found between the
NGT and FDR groups with regard to the
molar ratio between proinsulin and insulin
in the fasting state. Similarly, the I30-0/G30-0
ratio, used as an indicator of insulin secre-
tion, did not differ between the two groups.
Insulin resistance assessed by the HOMA
method did not differ between the two groups
(Table 2). However, a trend to higher values
was observed in the FDR-OB subgroup com-
pared to NGT-OB (2.53 vs 0.30; P = 0.075).
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Figure 1 - Plasma glucose levels
(mean ± SEM) during the oral
glucose tolerance test in control
subjects (NGT, N = 20) and first-
degree relatives (FDR, N = 15).
*P<0.05 compared to control
group (Mann-Whitney test).
Figure 2 - Plasma insulin levels
(mean ± SEM) during the oral
glucose tolerance test. A, Con-
trol subjects (NGT, N = 20) and
first-degree relatives with nor-
mal glucose tolerance (FDR, N =
15). B, Nonobese control group
(NGT-L, N = 11) and nonobese
relatives with normal glucose
tolerance (FDR-L, N = 7). C,
Obese control subjects (NGT-
OB, N = 9) and obese relatives
with normal glucose tolerance
(FDR-OB, N = 8). *P<0.05 com-
pared to control group (Mann-
Whitney test).
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these subjects were subdivided according to
BMI, among obese individuals those who
were relatives of NIDDM patients presented
significantly higher insulin levels under fast-
ing conditions and after glucose loading and
a trend to higher values in relative insulin
resistance as determined by HOMA. These
data indicate that, regardless of obesity, indi-
viduals with normal glucose tolerance and a
family history of diabetes are more insulin
resistant than those without diabetes among
their first-degree relatives.
The results of previous studies on insulin
and proinsulin levels in relatives of patients
with NIDDM have been contradictory. Geld-
ing et al. (11) and Roder et al. (12) reported
increased fasting insulin, but not proinsulin,
in first degree relatives of patients with
NIDDM, while others (13) found that both
insulin and proinsulin were increased among
the relatives. Kahn et al. (14), in a prospec-
tive study on Japanese-American men, a
population with a high prevalence of DM,
observed that subjects who subsequently
developed diabetes had higher proinsulin
levels at baseline than those who continued
to have NGT or IGT. These data indicate that
an increase in proinsulin levels may be a risk
factor for the subsequent development of
non-insulin-dependent diabetes mellitus.
The importance of insulin resistance and
of abnormal insulin secretion as a primary
factor in the development of diabetes melli-
tus is still a controversial matter. Haffner et
al. (15) observed that among Mexican-Ameri-
cans with normal glucose tolerance, both
insulin resistance and a decrease in insulin
secretion were predictive factors for the de-
velopment of NIDDM. In the present study,
in which insulin secretion was assessed on
the basis of the ratio of the increased insulin
to increased glucose ratio at 30 min follow-
ing OGTT, no significant differences were
observed among individuals with normal glu-
cose tolerance with or without a family his-
tory of diabetes, even when they were subdi-
vided according to body mass index.
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Figure 3 - Plasma proinsulin lev-
els (mean ± SEM) during the oral
glucose tolerance test. A, Con-
trol subjects (NGT, N = 20) and
first degree-relatives with nor-
mal glucose tolerance (FDR, N =
15). B, Nonobese control sub-
jects (NGT-L, N = 11) and
nonobese relatives with normal
glucose tolerance (FDR-L, N =
7). C, Obese control subjects
(NGT-OB, N = 9) and obese rela-
tives with normal glucose toler-
ance (FDR-OB, N = 8). *P<0.05
compared to control group
(Mann-Whitney test).
Table 2 - Metabolic measurements of control subjects
(NGT) and relatives (FDR).
Data are reported as median (range). PI/I, Proinsulin/
insulin ratio; I30-0/G30-0, ratio of the 30-min increment of
insulin to glucose concentrations following the OGTT;
HOMA, homeostasis model assessment.
NGT FDR P value
(N = 20) (N = 15)
PI/I (%) 16.97 (2.2-58.6) 5.48 (3.4-9.0) 0.26
I30-0/G30-0 4.15 (1.0-5.9) 2.85 (2.1-7.3) 0.50
HOMA (R) 0.98 (0.1-3.8) 1.87 (0.1-5.2) 0.16
Discussion
In the present study, both plasma insulin
and proinsulin levels after oral glucose load-
ing were higher in subjects with normal glu-
cose tolerance and first-degree relatives of
patients with NIDDM compared to subjects
without a family history of diabetes. When
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An increased proportion of proinsulin to
insulin, i.e., an increase in the proinsulin/
insulin ratio, is thought to reflect abnormal
ß-cell function (16). This alteration may be
due to an intrinsic abnormality in the conver-
sion of proinsulin to insulin or may be the
result of an increased demand for insulin
leading to the release of immature granules
rich in proinsulin (17). Several studies have
demonstrated a disproportionate increase in
proinsulin in patients with NIDDM (18-20);
however, few data are available about high-
risk subjects with normal glucose tolerance.
Haffner et al. (15) have shown that nondia-
betic Mexican-Americans with a parental
history of diabetes have a disproportionate
elevation in proinsulin relative to insulin. In
contrast, two other reports concerning Pima
Indians (19) and Finnish subjects (20) did
not find an increase in the proinsulin/insulin
ratio. Similarly, among the individuals evalu-
ated in the present study we did not find a
qualitative change in ß-cell function when
subjects with normal glucose tolerance with
and without a family history of diabetes
were compared. One of the possible expla-
nations for this discrepancy may be the eth-
nic difference of the groups studied. Further-
more, previous reports showed that the in-
crease in the proinsulin/insulin ratio is asso-
ciated with the severity of hyperglycemia
(20) and is reversible by the normalization of
glycemia through the diet or with the use of
sulfonylurea (21). However, we cannot rule
out the possibility of the existence of an
intrinsic defect in beta cells among subjects
at high risk to develop non-insulin depend-
ent diabetes mellitus that will not manifest
overtly while normoglycemia is maintained.
We found that first-degree relatives of
patients with NIDDM, who are at high risk to
develop the disease, presented high proinsu-
lin and insulin levels in an assay that does
not cross-react with proinsulin, reflecting
insulin resistance and no dysfunction of a
qualitative nature in ß-cells.
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